1 insider has bought $102k of Anteris Technologies Global Corp. shares across 1 disclosed dealing since June 2026.
| Jun 2, 2026 | Knight Susan Elizabeth — director | $102,229 |
Anteris Technologies Global Corp. is classed as health care. By value disclosed, that ranks 28th of the 44 health care companies where insiders bought in the last twelve months.
Companies with a comparable amount of disclosed buying: NEONC TECHNOLOGIES HOLDINGS, INC. · Tonix Pharmaceuticals Holding Corp. · Annovis Bio, Inc. · Verrica Pharmaceuticals Inc. · ADMA BIOLOGICS, INC. · DarioHealth Corp.
See also the biggest buys, cluster buying and the most-active companies.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Every row is a public regulatory disclosure — a Form 4 filing with the SEC — collected within minutes of being published. We don’t take company submissions and we don’t edit the numbers; the only thing we add is the rating and the reasoning behind it.
Sometimes. A insider buying with their own money is one of the few honest signals in the market, but plenty of purchases are routine — small top-ups, scheme allocations, or a well-paid executive rounding out a holding. That’s what our six-point check is for: it separates the conviction buys from the housekeeping, and shows you which is which.
The pipeline runs every 15 minutes through the trading day, so a new disclosure appears here shortly after it’s filed. Company stats refresh daily.
Yes — that’s what the app is for. Follow Anteris Technologies Global Corp. and you’ll get a push the moment a insider files, with the full analysis attached, plus alerts if the price moves after a buy you’re following.
No. ddbx rates the conviction behind insider buys and shows the reasoning. It’s information, never a recommendation, and never a guarantee. What you do with it is your call.